newsfilter
← Latest News
GlobeNewswire·

Unicycive Therapeutics to Participate in Upcoming Investor Events in September

LOS ALTOS, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the "Company" or